erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain. .
mrs cavanagh, from foyle park in londonderry, had a complex medical history of chronic heart and renal failure. .
the medical experts are worse. their pretense of idealism knows no limits, and is matched only by their claim to bullet-proof knowledge. .
over years of research, scientists discovered that cgrp helps transmit pain signals in the brain.
181 Used Today
200 Used Today